Literature DB >> 35393080

Neurophysiological Deficits During Reappraisal of Negative Emotional Stimuli in Opioid Misuse.

Justin Hudak1, Edward M Bernat2, Spencer T Fix2, Kort C Prince3, Brett Froeliger4, Eric L Garland5.   

Abstract

BACKGROUND: Opioid misuse is hypothesized to compromise the ability to regulate negative emotions, as manifested through visceral and peripheral physiological signals. However, neurophysiological impairment of top-down cognitive emotion regulation in opioid misuse has not previously been shown.
METHODS: Patients with chronic pain who had been taking opioids for 90 days or longer (N = 149; female, n = 98) underwent a negative emotion regulation task with electroencephalography. Participants were instructed to view or reappraise negative images presented for 3 seconds. Using a validated cutoff score on the Current Opioid Misuse Measure, participants were classified as exhibiting aberrant drug-related behavior consistent with opioid misuse (MISUSE+) or as being low risk for opioid misuse (MISUSE-). Participants reported their craving in response to negative emotions over the past week.
RESULTS: We observed a group × condition interaction (p = .003) such that the MISUSE- group decreased the late positive potential of the electroencephalography during reappraisal, whereas the MISUSE+ group showed increased late positive potential during reappraisal. This deficit in negative emotion regulation remained significant after controlling for an array of potential confounding variables, including opioid dose, pain, and depression. Heightened late positive potential during reappraisal was associated with more severe opioid craving.
CONCLUSIONS: Opioid misuse may occasion top-down deficits in emotional regulation that begin as early as 400 ms after presentation of negative stimuli. It remains unknown whether emotion dysregulation is the cause, correlate, or consequence of opioid misuse. Nonetheless, targeting emotion dysregulation in opioid misuse with reappraisal-focused interventions may represent an important treatment approach.
Copyright © 2022 Society of Biological Psychiatry. All rights reserved.

Entities:  

Keywords:  Chronic pain; Craving; Emotion regulation; Opioid misuse; Opioid use disorder; Reappraisal

Mesh:

Substances:

Year:  2022        PMID: 35393080      PMCID: PMC9167218          DOI: 10.1016/j.biopsych.2022.01.019

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   12.810


  31 in total

1.  Rethinking feelings: an FMRI study of the cognitive regulation of emotion.

Authors:  Kevin N Ochsner; Silvia A Bunge; James J Gross; John D E Gabrieli
Journal:  J Cogn Neurosci       Date:  2002-11-15       Impact factor: 3.225

Review 2.  Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis.

Authors:  A Baldacchino; D J K Balfour; F Passetti; G Humphris; K Matthews
Journal:  Neurosci Biobehav Rev       Date:  2012-07-06       Impact factor: 8.989

Review 3.  Significance?& Significance! Empirical, methodological, and theoretical connections between the late positive potential and P300 as neural responses to stimulus significance: An integrative review.

Authors:  Greg Hajcak; Dan Foti
Journal:  Psychophysiology       Date:  2020-04-03       Impact factor: 4.016

4.  Antecedent- and response-focused emotion regulation: divergent consequences for experience, expression, and physiology.

Authors:  J J Gross
Journal:  J Pers Soc Psychol       Date:  1998-01

5.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

6.  Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides.

Authors:  J C Buckingham
Journal:  Neuroendocrinology       Date:  1982       Impact factor: 4.914

Review 7.  Common Brain Mechanisms of Chronic Pain and Addiction.

Authors:  Igor Elman; David Borsook
Journal:  Neuron       Date:  2016-01-06       Impact factor: 17.173

8.  Reappraisal deficits promote craving and emotional distress among chronic pain patients at risk for prescription opioid misuse.

Authors:  Eric L Garland; Adam W Hanley; Carter E Bedford; Jon-Kar Zubieta; Matthew O Howard; Yoshio Nakamura; Gary W Donaldson; Brett Froeliger
Journal:  J Addict Dis       Date:  2018-06-04

Review 9.  Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.

Authors:  Kevin E Vowles; Mindy L McEntee; Peter Siyahhan Julnes; Tessa Frohe; John P Ney; David N van der Goes
Journal:  Pain       Date:  2015-04       Impact factor: 6.961

10.  The temporal dynamics of emotion dysregulation in prescription opioid misuse.

Authors:  Justin Hudak; Kort C Prince; William R Marchand; Yoshio Nakamura; Adam W Hanley; Craig J Bryan; Brett Froeliger; Eric L Garland
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-06-24       Impact factor: 5.067

View more
  1 in total

1.  Mindfulness-Oriented Recovery Enhancement for Addictive Behavior, Psychiatric Distress, and Chronic Pain: A Multilevel Meta-Analysis of Randomized Controlled Trials.

Authors:  Anna Parisi; R Lynae Roberts; Adam W Hanley; Eric L Garland
Journal:  Mindfulness (N Y)       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.